Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00104481 · ClinicalTrials.gov registry record · Phase 1

Group Counseling for Smoking Cessation

A Phase 1 study of Smoking, sponsored by American University.

Completed
Registry status
Phase 1
Development phase
240
Enrollment target
1
Study location

NCT00104481 is a Phase 1 study of Smoking that has completed, run by American University. The registered enrollment target is 240 participants, below the 453-participant average among 123 other Smoking trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00104481, a Phase 1 study of Smoking, has completed, sponsored by American University.

COMPLETED
Registry status
Phase 1
Development phase
240 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the effectiveness of group therapy for cigarette smoking cessation. The group meets for 8 sessions and includes education and group discussion about the effects of smoking and ways to cope with withdrawal symptoms and other challenges to maintaining abstinence. In one condition, the groups also learn techniques based on cognitive therapy, to help cope with negative feelings.

Conditions Studied

Interventions

  • BEHAVIORAL cognitive behavior therapy

Study Locations (1)

District of Columbia

  • American University - Washington D.C.

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2005-01
Est. Completion 2007-08
Phase Phase 1

Sponsor

American University

16 total trials

What the Registry Record Tells You About NCT00104481

The ClinicalTrials.gov registry entry for NCT00104481 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 453-participant average among 123 other Smoking trials with a reported enrollment target (47% lower). The listed sponsor is American University, which has 16 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Smoking appearing as the primary indexed condition, and to 1 intervention - of which cognitive behavior therapy is the first listed.

NCT00104481 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.

Frequently Asked Questions

What is clinical trial NCT00104481 about?

NCT00104481 is a clinical study titled "Group Counseling for Smoking Cessation". The purpose of this study is to evaluate the effectiveness of group therapy for cigarette smoking cessation. The group meets for 8 sessions and includes education and group discussion about the effects of smoking and ways to cope with withdrawal symptoms and other challenges to maintaining abstinenc...

What is the current status of trial NCT00104481?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 240 participants. The study started on 2005-01. Estimated completion is 2007-08.

What conditions does trial NCT00104481 study?

This clinical trial studies the following conditions: Smoking.

What interventions are being tested in trial NCT00104481?

The interventions under investigation include: cognitive behavior therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00104481?

This trial is sponsored by American University, which has 16 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00104481 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Smoking

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.